My average is $4.49 now after averaging down many times..... and I think that's going to be a very profitable price per share to be averaged at. Hell I'm almost glad it dropped like this first of the year, gave me plenty of time to buy more!
They get the NDA for cIAI and I believe this can see $20+ again easy. Everacycline made it through phase 3 already showing good results and safety profile. What reason does the FDA have to not give them this approval? They can work on cUTI approval in the meantime while bringing in revenue from cIAI.
Market Data 
Markets 
AI
